SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-16-016776
Filing Date
2016-04-27
Accepted
2016-04-27 16:40:41
Documents
5
Period of Report
2016-06-02
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A xene-def14a_20160602.htm DEF 14A 2874074
2 GRAPHIC grj5t1axi23x000003.jpg GRAPHIC 20148
3 GRAPHIC grj5t1axi23x000002.jpg GRAPHIC 3078
4 GRAPHIC grj5t1axi23x000004.jpg GRAPHIC 2099
5 GRAPHIC grj5t1axi23x000001.jpg GRAPHIC 3078
  Complete submission text file 0001564590-16-016776.txt   2914823
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36687 | Film No.: 161595909
SIC: 2834 Pharmaceutical Preparations